ONC, CMS rulings push the needle on FHIR adoption
View As Webpage

NTT Data
 
HIMSS
 
 

Thursday, July 23, 2020

 
 
Dr. Lynae Brayboy
 

Hims eyes deal to go public and expands its remote mental health services >>

 

BY DAVE MUOIO

Consumer wellness and telehealth company Hims could be the next to throw its hat into the public markets.
 

According to a report from Reuters, the startup is weighing a potential sale to an unnamed special purpose acquisition company (SPAC) – a "blank-check company" that uses the proceeds of an IPO to acquire or merge another business.
 

The deal would value Hims at over $1 billion, Reuters' sources said, although the telehealth brand is also considering other deal options. Hims declined to comment on the news to MobiHealthNews.
 

News of the plans comes as the company announced another expansion to its virtual mental health offerings. In addition to the free group sessions launched in the spring, the Hims and Hers brands are offering one-on-one sessions with licensed providers for treatment of anxiety and depression.
 

The individual counseling is rolling out first in New York and California, the company said, with expansions to other parts of the U.S. planned for later in the year.
 

And to support it, Hims has picked up Julian Cohen, previously the cofounder of Breakthrough Behavioral (which was acquired by MDLive) and a behavioral health division lead at Teladoc. He will be stepping into the new role at Hims as SVP of behavioral health.
 

“Hims & Hers was founded to break down the barriers to accessing care and eliminate stigma, both critically important efforts if we want to improve mental healthcare in this country,” Cohen said in a statement. “I’m thrilled to be joining the company to continue to build out its mental health category of care, and help Hims & Hers address the increasing need for mental health providers and treatments.”
 

WHY IT MATTERS
 

Just past the midway point of the year, 2020's public markets have been good to digital health companies. New IPOs from names like One Medical and Accolade have each performed well, while others like Teladoc Health and Livongo have seen their share prices skyrocket as a result of COVID-19.
 

These performances; recent word that AmWell, another telemedicine giant, is also looking to go public; and Hims' newly revealed plans all suggest a level of confidence that was absent during the digital health industry's roughly three-year IPO lull.
 

The mental health expansion, meanwhile, brings another option to consumer-friendly behavioral healthcare. With initial consultations set at $59 and a key strategic hire, it looks like the company is serious about slicing itself a piece of the behavioral telehealth pie.
 

THE LARGER TREND
 

While new digital behavioral health offerings enter the market at a fairly steady clip, the COVID-19 emergency and broad calls for more mental health options appear to have driven new support for virtual behavioral health services. Mindfulness app makers Headspace and Big Health both saw solid fundraises within the last few months, while Omada  and others began offering mental health components of their platforms for free during the COVID-19 emergency.
 

There is also some evidence from market observers that increased utilization of these services doesn't represent an unusual spike, but the continuation of a steady upward trend.


woman holding a cellphone
 

WHO's director for Europe urges solidarity in using digital tools to combat COVID-19 >>

 

BY LAURA LOVETT

Within the first few months of the coronavirus pandemic, Europe was one of the hardest hit regions. When the disease first began to spread, countries quickly looked for ways to treat the virus and stop the transmission. This led to the deployment of a vast array of digital tools.
 

“The WHO has been advocating for many years to strategically invest in digital health and digital health systems, be it to help transforming health systems – boosting new models of service delivery to educate the population of the role of digital health in prevention, care and monitoring,” Dr. Hans Henri Kluge, the World Health Organization’s director for Europe, said during a FutureMed presentation this afternoon. 
 

He noted that the coronavirus pandemic has boosted the adoption of digital tools and scaled these technologies. However, going into the next digital age, he warned that it’s important to learn from the past. 
 

“The key issue here is not to repeat the pitfalls from the past that we are aware of, mainly on the governance, the interoperability, the trust for digital health,” he said. 
 

Digital contact-tracing tools have become a popular way to help governments track the spread of the disease. Kluge reported that 27 out of the 53 countries in WHO’s European region have some kind of digital contract-tracing solution, with even more in the works. But he said there is some danger of repeating the past.  
 

“We know there is still no final here on the complete effectiveness,” he said. “We know most of the issues. It has to do with ethics, with human rights, with privacy and one word…. trust.”
 

Worldwide, contact-tracing tools have come under fire for questionable privacy practices. In June Amnesty International published a new report that claimed Norway, Bahrain and Kuwait had “some of the most invasive COVID-10 contact-tracing apps around the world.” Since the report Norway stopped its app. Kluge said that trust is important beyond the coronavirus pandemic.
 

“The trust issue is at the core of my vision. What I would like to do, the vision for the next five years in the WHO European region, is to help health authorities and empower them to help to answer to the legitimate concerns that people have towards their health authorities.”
 

Although tracing tools have become popular, Kluge said that there has always been a segment of the population that is unwilling to share data with health authorities. 
 

“Let’s not pinpoint or stigmatize those portions of the population, but design solutions or operational approaches which take into account those people,” he said. 
 

Today all eyes are on using digital to treat and track the coronavirus. However, Kluge said that even during this time digital can have more use cases. 
 

“A lot of people are still passing away due to coronavirus, but a whole group of people are suffering because they do not get the treatment for a whole lot of other pandemics – the pandemic of cardiovascular disease, the pandemic of diabetes, of cancer. So, that is, I think, where digital health can make a huge impact in terms of equity and population-based impact,” he said. “On COVID-19 everyone is focused on it. I’m less worried. I’m more worried: How do we leverage digital health to decrease and avoid excess mortality?”
 

Mental health is one of those health conditions. He noted that the lockdown may have large consequences on mental health, and digital could be one solution to combating those health issues. 
 

Kluge also sees digital having an impact on medical misinformation. 
 

“Let’s think of how to take advantage of digital health for vaccination records and reminders. We know that vaccination works. [There's] still a huge question mark about COVID vaccines, but we know that vaccines for seasonal flu work, so let’s take advantage. Also, to beef up health information and decrease what I call [the] ‘infodemic’ – misinformation. So, I would say that is something that, very quickly, we can make a huge impact – by decreasing mortality and boosting health,” he said. 
 

The World Health Organization has teamed up with tech giants like Facebook and Google to help curb the spread of coronavirus-based health misinformation. 
 

Going forward, Kluge warned that digital tools need to be for all populations – especially when fighting something like a global pandemic.
 

“As a health leader I cannot and will not allow that we are going to have another divide. The vulnerable people were hit harder, so we cannot afford another digital divide,” he said. “If there’s one thing COVID-19 has [taught] me, it’s that no one is safe until everyone is safe, so let’s see this, including digital health, as a boost to international solidarity.” 


 

ADVERTISEMENT

Optum
 

DIGITAL HEALTH

Chugai and Biofourmis to develop digital pain assessment tool for patients with endometriosis >>

The partnership leverages Biofourmis’ Biovitals platform to co-develop a novel digital technology for the objective assessment of pain using biosensors and AI-based algorithms.

 

FUNDING AND IPOS

Insurance startup Sidecar Health closes $20M for point-of-service payments >>

The startup provides users with price transparency tools and a Visa card for healthcare payments at cash rates.

 

INNOVATION

MassChallenge names winners of 2020 program, with focus on Parkinson's, home health and cardiac rehab >>

Walk with Path, Moving Analytics, and MedFlyt were named the top startups from the accelerator program this year.

 

AI, DATA AND, ANALYTICS

QUIBIM secures $9.2M for radiology AI platform that detects COVID-19 >>

The AI-integrated software can be used for early detection of COVID-19 and other diseases through imaging biomarkers in Europe.

 

HIMSS TV

ONC, CMS rulings push the needle on FHIR adoption >>

John D'Amore, president and cofounder of Diameter Health, discusses the future of interoperability in the U.S.

 

HIMSS INSIGHTS

COVID-19 and Beyond >>

The latest issue in the HIMSS Insights series focuses on the implications of the coronavirus crisis for healthcare and healthcare digitization. Several months into the crisis at the time of publication, we try to identify major trends coming out of COVID-19 and unmet digital needs that are being unmasked. The second area of focus is digital health technology assessment which is arising in several healthcare systems and remains highly relevant during the pandemic and beyond.

 

ADVERTISEMENT

HIMSS Analytics
 
 

Real-time analytics, during the pandemic and beyond >>

 

PUTTING DATA TO WORK

This month, we look at the lasting lessons from the COVID-19 crisis about how data is exchanged, how it's managed, how it's visualized, how it's put to work informing patient care decisions and population health.

Facebook Twitter LinkedIn

MobiHealthNews & HIMSS Media.
Editorial Inquiries | Advertising | Privacy Policy | Unsubscribe

33 West Monroe Street, Suite 1700, Chicago, IL 60603-5616